Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan-Jun;14(1):50-53.
doi: 10.4103/tp.tp_25_23. Epub 2024 Feb 15.

Nitazoxanide refractory cryptosporidiosis complicating Burkitt lymphoma in a child

Affiliations

Nitazoxanide refractory cryptosporidiosis complicating Burkitt lymphoma in a child

Salman Khan et al. Trop Parasitol. 2024 Jan-Jun.

Abstract

Cryptosporidium species cause watery diarrhea in several vertebrate hosts, including humans. Most apparently, immunocompetent-infected individuals remain asymptomatic, whereas immunocompromised may develop severe or chronic cryptosporidiosis. We report here the case of a 6-year-old girl undergoing chemotherapy for Burkitt lymphoma who experienced multiple episodes of watery diarrhea during her hospital stay. Microscopic examination of her stool sample revealed oocysts of Cryptosporidium species. The rapid immunochromatographic test was also positive for Cryptosporidium species. She was treated with nitazoxanide for 3 weeks, which failed to provide both clinical improvement and parasitological clearance. This case highlights the importance of treatment failure in human cryptosporidiosis.

Keywords: Burkitt lymphoma; Cryptosporidium species; nitazoxanide; refractory.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Oocyst of Cryptosporidium species (black arrow) in modified acid-fast stained smear of stool specimen (×400)
Figure 2
Figure 2
Rapid immunochromatographic test showing positive test band for Cryptosporidium species (red arrow) and control band (green arrow)

Similar articles

References

    1. Gharpure R, Perez A, Miller AD, Wikswo ME, Silver R, Hlavsa MC. Cryptosporidiosis outbreaks –United States, 2009-2017. MMWR Morb Mortal Wkly Rep. 2019;68:568–72. - PMC - PubMed
    1. Diptyanusa A, Sari IP. Treatment of human intestinal cryptosporidiosis: A review of published clinical trials. Int J Parasitol Drugs Drug Resist. 2021;17:128–38. - PMC - PubMed
    1. Innes EA, Chalmers RM, Wells B, Pawlowic MC. A one health approach to tackle cryptosporidiosis. Trends Parasitol. 2020;36:290–303. - PMC - PubMed
    1. Checkley W, White AC, Jr, Jaganath D, Arrowood MJ, Chalmers RM, Chen XM, et al. Areview of the global burden, novel diagnostics, therapeutics, and vaccine targets for Cryptosporidium. Lancet Infect Dis. 2015;15:85–94. - PMC - PubMed
    1. El-Alfy ES, Nishikawa Y. Cryptosporidium species and cryptosporidiosis in Japan: A literature review and insights into the role played by animals in its transmission. J Vet Med Sci. 2020;82:1051–67. - PMC - PubMed